Published in Br J Haematol on July 23, 2009
The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood (2010) 2.17
High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood (2010) 1.44
Verbal autopsy as a tool for identifying children dying of sickle cell disease: a validation study conducted in Kilifi district, Kenya. BMC Med (2014) 1.03
Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania. Haematologica (2011) 0.89
Routine paediatric sickle cell disease (SCD) outpatient care in a rural Kenyan hospital: utilization and costs. PLoS One (2013) 0.88
Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda. Afr Health Sci (2015) 0.83
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial. Pediatr Blood Cancer (2015) 0.80
Sickle-cell disease in febrile children living in a rural village of Madagascar and association with malaria and respiratory infections. BMC Hematol (2016) 0.77
Nocturnal haemoglobin oxygen desaturation in urban and rural East African paediatric cohorts with and without sickle cell anaemia: a cross-sectional study. Arch Dis Child (2015) 0.76
The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria. Clinicoecon Outcomes Res (2015) 0.75
Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo. Hematol Rep (2017) 0.75
Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions. Br J Haematol (2017) 0.75
Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood (1998) 6.72
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med (2000) 4.14
Natural history of sickle cell disease--the first ten years. Semin Hematol (1975) 3.53
Periodicity and space-time clustering of severe childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg (1993) 3.16
Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg (1997) 2.42
Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg (2008) 2.29
Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature (1978) 2.28
Children with severe malnutrition: can those at highest risk of death be identified with the WHO protocol? PLoS Med (2006) 2.16
Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet (2003) 2.15
Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci U S A (1978) 2.14
[The liver in sickle cell anemia]. Bull Johns Hopkins Hosp (1953) 2.12
Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet (2001) 2.00
Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr (2004) 1.90
Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease. Br J Haematol (2005) 1.86
Maintenance of high sickling rate in an African community. Br Med J (1956) 1.75
[Sickle cell disease in children in Dakar, Senegal]. Arch Pediatr (2000) 1.63
Sickle-cell disease in Brazzaville, Congo: genetical, hematological, biochemical and clinical aspects. Acta Haematol (1999) 1.60
The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years. Br J Haematol (1981) 1.54
Asthma and acute chest in sickle-cell disease. Pediatr Pulmonol (2004) 1.53
Pulse oximetry in a cohort study of sickle cell disease. Clin Lab Haematol (1997) 1.47
The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev (1989) 1.43
Sickle cell disease in Africa. Curr Opin Hematol (2002) 1.41
Sleep related upper airway obstruction and hypoxaemia in sickle cell disease. Arch Dis Child (1992) 1.39
Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood (2003) 1.35
Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.30
The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun (2006) 1.28
Outcome of holistic care in Nigerian patients with sickle cell anaemia. Clin Lab Haematol (2005) 1.21
The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder. Blood Rev (2004) 1.19
Malaria parasite density and splenic status by ultrasonography in stable sickle-cell anaemia (HbSS) children. Niger J Med (2004) 1.15
Abnormal haemoglobins in the Sudan savanna of Nigeria. III. Malaria, immunoglobulins and antimalarial antibodies in sickle cell disease. Ann Trop Med Parasitol (1979) 1.13
Pulmonary manifestations of sickle cell disease. Postgrad Med J (2003) 1.10
Anthropometric finding in Nigerian children with sickle cell disease. Pediatr Dent (2002) 1.08
Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trop Med Int Health (1997) 1.06
Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci (1986) 1.03
Benign clinical course in homozygous sickle cell disease: a search for predictors. J Clin Epidemiol (1997) 1.01
Liver involvement in sickle cell disease. Medicine (Baltimore) (1985) 1.00
Malarial parasitaemia in febrile children with sickle cell anaemia. J Trop Pediatr (1992) 0.98
Snoring, daytime sleepiness, and sickle cell anemia. Am J Dis Child (1988) 0.92
[Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects]. Dakar Med (2000) 0.92
A survey of the incidence of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Zambia. Trans R Soc Trop Med Hyg (1970) 0.91
Persistent gross splenomegaly in Nigerian patients with sickle cell anaemia: relationship to malaria. Ann Trop Paediatr (1988) 0.91
New results in clinical severity of homozygous sickle cell anemia, in Dakar, Senegal. Hematol Cell Ther (1999) 0.91
Studies in sickle cell anemia. XXVII. Complications in infants and children in the United States. Clin Pediatr (Phila) (1966) 0.88
Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J (1994) 0.86
Chronic tonsillitis, tonsillectomy and sickle cell crises. J Laryngol Otol (1987) 0.86
Nutritional iron status in children with alpha+ thalassemia and the sickle cell trait in a malaria endemic area on the coast of Kenya. Haematologica (2005) 0.86
Haplotypes and alpha globin gene analyses in sickle cell anaemia patients from Kenya. Br J Haematol (1987) 0.86
Spleen in sickle cell anemia: comparative studies of Nigerian and U.S. patients. Am J Hematol (1993) 0.83
[The importance of sickle cell anemia in a pediatric environment in Gabon]. Sante Publique (1997) 0.82
[Prognosis of sickle cell anemia in Belgian Congo; based on 300 cases and 150 deaths]. Ann Soc Belg Med Trop (1920) (1955) 0.81
Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome. Trop Geogr Med (1992) 0.79
Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults. Ann Trop Med Parasitol (1983) 0.79
Studies in sickle-cell anemia. XII. Further studies on hepatic function in sickle-cell anemia. AMA J Dis Child (1959) 0.77
[Mortality of children with sickle cell disease in a pediatric department in Central Africa]. Arch Pediatr (1998) 0.77
Sickle cell anaemia in adult Zambian Africans. Cent Afr J Med (1980) 0.77
Plasmodium falciparum malaria: its effects on some haematological parameters in normal and sickle cell Nigerian children. Trop Med Parasitol (1994) 0.76
Sicklers surviving childhood in Tanzania. Trop Geogr Med (1979) 0.76
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
The pathogenic basis of malaria. Nature (2002) 10.44
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
The decline in paediatric malaria admissions on the coast of Kenya. Malar J (2007) 7.45
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol (2002) 6.01
Immunity to malaria: more questions than answers. Nat Immunol (2008) 5.71
Sickle-cell disease. Lancet (2010) 5.64
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med (2004) 4.76
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet (2009) 4.76
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet (2012) 4.62
Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet (2013) 4.54
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis (2005) 4.44
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res (2009) 3.99
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet (2011) 3.78
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine (2004) 3.51
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell (2013) 3.49
Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia (2011) 3.48
Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med (2011) 3.35
Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ (2005) 3.34
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia (2010) 3.33
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA (2007) 3.29
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet (2004) 3.25
Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis (2005) 3.12
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Traditional healers and epilepsy treatment on the Kenyan coast. Epilepsia (2008) 2.88
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis (2009) 2.80
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
Clinical features and pathogenesis of severe malaria. Trends Parasitol (2004) 2.73
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis (2010) 2.68
The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia (2008) 2.66
Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol (2012) 2.64
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature (2004) 2.56
Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors. Lancet Neurol (2008) 2.52
Heritability of malaria in Africa. PLoS Med (2005) 2.49
Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun (2010) 2.46
Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Trop Med Int Health (2005) 2.46
Malaria in Africa: progress and prospects in the decade since the Abuja Declaration. Lancet (2010) 2.41
Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med (2013) 2.36
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother (2009) 2.36
Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis (2004) 2.34
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials (2006) 2.33
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg (2008) 2.29
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol (2013) 2.28
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med (2013) 2.24
Defining childhood severe falciparum malaria for intervention studies. PLoS Med (2007) 2.22
Valid consent for genomic epidemiology in developing countries. PLoS Med (2007) 2.14
Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog (2005) 2.13
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun (2011) 2.11
An immune basis for malaria protection by the sickle cell trait. PLoS Med (2005) 2.08
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 2.07
The global distribution of the Duffy blood group. Nat Commun (2011) 2.06
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS One (2011) 2.00
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest (2008) 1.96
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol (2002) 1.95
Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis (2007) 1.94
The effects of untreated bednets on malaria infection and morbidity on the Kenyan coast. Trans R Soc Trop Med Hyg (2004) 1.91
Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr (2004) 1.90
The role of the district hospital in child survival at the Kenyan Coast. Afr J Health Sci (1994) 1.90
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine (2005) 1.89
Chloroquine resistance before and after its withdrawal in Kenya. Malar J (2009) 1.88
Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital. Bull World Health Organ (2003) 1.87
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study. Lancet Neurol (2012) 1.87
Plasmodium falciparum var gene expression is modified by host immunity. Proc Natl Acad Sci U S A (2009) 1.86
Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood (2006) 1.83
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun (2009) 1.79